Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 11590992)

1.

Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study.

Cammarota S, Falconio LM, Bruzzese D, Catapano AL, Casula M, Citarella A, De Luca L, Flacco ME, Manzoli L, Masulli M, Menditto E, Mezzetti A, Riegler S, Novellino E, Riccardi G.

PLoS One. 2013 Nov 7;8(11):e79762. doi: 10.1371/journal.pone.0079762. eCollection 2013.

2.

Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

Canadian Agency for Drugs and Technologies in Health (CADTH).

CADTH Technol Overv. 2010;1(1):e0110. Epub 2010 Mar 1. No abstract available.

3.

Insulin glulisine in the management of diabetes.

Yamada S.

Diabetes Metab Syndr Obes. 2009 Jul 7;2:111-5.

4.

Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes.

Philotheou A, Arslanian S, Blatniczky L, Peterkova V, Souhami E, Danne T.

Diabetes Technol Ther. 2011 Mar;13(3):327-34. doi: 10.1089/dia.2010.0072. Epub 2011 Feb 3.

5.

An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.

Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ.

Diabet Med. 2009 Aug;26(8):803-14. doi: 10.1111/j.1464-5491.2009.02775.x. Review.

6.

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.

Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H.

CMAJ. 2009 Feb 17;180(4):385-97. doi: 10.1503/cmaj.081041.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk